Please login to the form below

oral octreotide acetate

This page shows the latest oral octreotide acetate news and features for those working in and with pharma, biotech and healthcare.

Roche licenses Chiasma’s acromegaly drug in $595m deal

The licensing deal - valued at up to $595m - is for Octreolin (oral octreotide acetate), a drug candidate which which is currently in phase III testing for acromegaly and also in development ... Our oral octreotide has the potential to improve the

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Account Manager, MedicalCommunications/ Healthcare PR: benefits

PR Director – Health & Wellbeing – Mat Cover (4 days a week)...: Salary TBC

AD – Corporate Comms/ Public Affairs/ B2B – Healthcare Focus: Salary TBC

Digital Account Director: Salary TBC

Account Director, Healthcare Marketing Agency: Salary TBC

Senior Medical Writer: Up to £50, 000 with Benefits

Project/ Events Manager – Medical Education and Events Agency: Salary TBC

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Project Manager/ Account Manager: Salary TBC

Senior Medical Writer: Great salary and benefits

Senior Medical Writer: Salary TBC

Account Director, Medical Education: Salary TBC

Senior Planner – Healthcare Advertising – New Role: Salary TBC

Account/ Project Director – Medical Affairs – Surrey: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

International Childhood Cancer Day 2019: The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues: Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups: A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...